ENANTA PHARMACEUTICALS INC — Director's Dealing 2021

Jan 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENANTA PHARMACEUTICALS INC (ENTA)
CIK: 0001177648
Period of Report: 2021-01-26

Reporting Person: Or Yat Sun (Sr. VP & CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-26	Common Stock	M	5149	$14.18	Acquired	322374	Direct
2021-01-26	Common Stock	M	3672	$11.77	Acquired	326046	Direct
2021-01-26	Common Stock	M	4872	$11.77	Acquired	330918	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-26	Stock Option (Right to Buy)	$14.18	M	5149	Disposed	2022-12-26	Common Stock (5149)	Direct
2021-01-26	Stock Option (Right to Buy)	$11.77	M	3672.0	Disposed	2022-06-20	Common Stock (3672.0)	Direct
2021-01-26	Stock Option (Right to Buy)	$11.77	M	4872	Disposed	2022-06-20	Common Stock (4872)	Direct

Footnotes

F1: 100% of the shares subject to the option are fully vested and exercisable.